What Makes Integrative Cardiology Different From Conventional Cardiology?

Atherosclerosis Burden: Coronary artery calcium (CAC) scoring to quantify plaque.
Familial Hypercholesterolemia (FH): When history or labs suggest FH, gene testing (e.g., LDLR, APOB, PCSK9) can confirm diagnosis and inform intensity of lipid-lowering therapy and cascade screening.
CAC quantifies calcified plaque burden (event prediction).
Evidence-Informed Nutraceuticals: When appropriate, options such as omega-3s, soluble fiber/plant sterols, or specific micronutrients may complement medications—selected for quality and interactions, and monitored for effect.
Overview
How The Philosophy Differs
What “Root-Cause” Means In Cardiology
Testing: Similar Tools, More Context
- Atherosclerosis Burden: Coronary artery calcium (CAC) scoring to quantify plaque.
- Lipid Nuance: apoB, Lp(a), small dense LDL, and triglyceride/HDL ratio to refine residual risk.
- Inflammation & Metabolism: high-sensitivity CRP, fasting insulin, glucose tolerance patterns, and liver fat surrogates.
- Sleep & Autonomic Tone: sleep apnea evaluation and heart-rate variability trends.
- Lifestyle & Social Factors: nutrition, activity, work stress, caregiving demands, and access to healthy resources.
Genetic Insights (When They Change Care)
- Lipoprotein(a) : Lp(a) levels are largely genetically determined and associated with residual atherosclerotic risk even when LDL is controlled.
- Familial Hypercholesterolemia (FH): When history or labs suggest FH, gene testing (e.g., LDLR, APOB, PCSK9) can confirm diagnosis and inform intensity of lipid-lowering therapy and cascade screening.
- Polygenic Risk Scores (PRS): In select prevention scenarios, PRS for coronary disease can help stratify baseline risk, especially when traditional scores are borderline.
- Pharmacogenomic Considerations: In limited cases, variants that affect drug metabolism or myopathy risk may be considered to personalize medication choice and dosing.
Imaging Beyond Standard: Vascular Age With CIMT
- CAC quantifies calcified plaque burden (event prediction).
- CIMT reflects arterial wall remodeling and early disease biology (trajectory and “age” signals).
Treatment: Medications Plus Personalization
- Personalization: We use your risk profile (apoB, Lp, CAC, CIMT trends, blood pressure patterns, kidney function, arrhythmia burden, and genetic context) to choose the right therapy at the right dose, and we actively monitor for side effects and alternatives if needed.
- Lifestyle As First-Line And Always-On: Structured nutrition (e.g., Mediterranean-style or cardiometabolic plans), resistance and aerobic training, sleep optimization, stress regulation, and tobacco cessation are built into your plan with granular steps.
- Evidence-Informed Nutraceuticals: When appropriate, options such as omega-3s, soluble fiber/plant sterols, or specific micronutrients may complement medications—selected for quality and interactions, and monitored for effect.
- Team-Based Care: Coaching, remote monitoring, and care coordination support you between visits, where most lifestyle change actually happens.
Procedures And Safety
Who Benefits Most
What To Expect At Holistic Heart Centers
Our Clinical Stance
How We Coordinate Care
Getting Started
References
- American College of Cardiology
- American Heart Association
- Centers for Disease Control and Prevention
- National Institutes of Health
More Articles on Heart Disease
-
Can Diet Reverse Heart Disease?
Read more →: Can Diet Reverse Heart Disease?Heart Disease Diet can contribute to reversing heart disease, particularly when it addresses the root causes of atherosclerosis like inflammation, insulin resistance, and oxidative stress. Clinical trials have demonstrated measurable plaque regression with intensive dietary intervention. However, diet alone may not be sufficient for everyone, especially those with advanced disease, genetic risk factors, or significant…
-
What Causes Heart Disease?
Read more →: What Causes Heart Disease?Heart Disease Heart disease is caused by damage to the blood vessels and heart muscle that accumulates over time. While cholesterol often receives the most attention, the actual disease process is driven by a combination of chronic inflammation, metabolic dysfunction, oxidative stress, and arterial damage. These factors interact to create atherosclerosis, the buildup of plaque…
-
Why Is Heart Disease The Leading Cause Of Death?
Read more →: Why Is Heart Disease The Leading Cause Of Death?Heart Disease Heart disease remains the leading cause of death worldwide because it develops silently over decades, is driven by common modern lifestyle factors, and is often detected too late requiring invasive intervention. The cardiovascular system is uniquely vulnerable to the cumulative effects of inflammation, metabolic dysfunction, and arterial damage. Unlike many other diseases, heart…
See all Heart Disease articles → | Back to Heart Health Blog
